Imunon, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Imunon, Inc. (IMNN) had Operating Leases, Future Minimum Payments, Due in Four Years of $379.82 thousand as of 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-03-29
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $379.82K; Operating Leases, Future Minimum Payments, Due in Four Years as first filed $458.00M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $297.11K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $23.20K.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $99.64K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years | Operating Leases, Future Minimum Payments, Due in Four Years as first filed |
|---|---|---|
| 2017-12-31 | $379.82K 10-K · filed 2019-03-29 | $458.00M 10-K · filed 2018-03-27 |
| 2016-12-31 | $297.11K 10-K · filed 2013-03-18 | |
| 2014-12-31 | $23.20K 10-K · filed 2015-03-12 | |
| 2013-12-31 | $99.64K 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |